GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Jul 2020 10:40

RNS Number : 3613T
Immunodiagnostic Systems Hldgs PLC
17 July 2020
 

Immunodiagnostic Systems Holdings plc

Director Dealing

17 July 2020

Immunodiagnostic Systems Holdings plc (IDH.L) ("IDS" or the "Company"), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets, was advised that today, Sander Perret Gentil, Head of Marketing and Communications, acquired 1,000 ordinary shares of 2p each ("Ordinary Shares") in the Company at an average price of £2.45 per Ordinary Share.

Following these purchases, Mr Perret Gentil is interested in 1,000 Ordinary Shares, 0.003% of the issued share capital of the Company.

For further information:

Immunodiagnostic Systems Holdings plc

Tel : +44 (0)191 519 0660

Paul Martin, Group Finance Director

Peel Hunt LLP

Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Sander Perret Gentil

2.

Reason for the notification

a.

Position/status

Head of Marketing and Communications

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Immunodiagnostic Systems Holdings plc

b.

LEI

213800HZMYTD4NGF4L78

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument,

type of instrument

Identification code

Ordinary shares of 2p each in Immunodiagnostic Systems Holdings plc

Ordinary shares

GB00B01YZ052

b.

Nature of the transaction

Purchase

c.

Price(s) and volume(s)

Price(s)

Volume(s)

£2.45

1000

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

2020-07-17

f.

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGCGDRCXBDGGR
Date   Source Headline
14th Apr 20057:01 amRNSResearch Agreement
21st Feb 200510:08 amRNSAcquisition
4th Feb 20054:30 pmRNSExercise of Options
18th Jan 20053:20 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.